Best IAS/PCS Coaching in Lucknow
×
Sign up as a User
Sign Up
Or Using
×
LogIn
Login
Call Us
+91-8756334461
Call Us
+91-7390000900
EMAIL US
prepareiascoaching@gmail.com
home
About Us
Faculty
Study Material
Prelims
MAINS
Essay
Current Affairs
Daily
Daily Editorial Analysis
Monthly
Gallery
Photo Gallery
Videos
Online Courses
Test Series
Prelims
Daily MAINS Ans. Writing
BLOGS
Contact US
Open Menu
home
About
Faculty
Courses
Study Material
Prelims
MAINS
Essay
Current Affairs
Daily
Daily Editorial Analysis
Monthly
Gallery
Videos
Online Courses
Test Series
Prelims
MAINS
Contact US
×
Quick Enquiry
Name
Phone
Email
Query
Submit
Quick Enquiry
About the Zy">
Current Affairs
Home
Current Affairs
Daily
Prepare IAS Coaching
Current Affairs
Title
: THE ZyCoV - D VACCINE (Prelims Specific Topic)
Date
: Dec 04, 2021
Description
:
About the ZyCov – D Vaccine:
Only people between the ages of 12 and 19 are eligible for the vaccine.
A needle-free applicator is used to deliver ZyCov – D.
It comes in three doses. It's given on the 28th and 56th days after the first dose.
It is priced at Rs 376.
It has shown to be 66.6 percent effective.
Cadila Healthcare, an Indian pharmaceutical business, produced the vaccine.
How it is created:
It has been created using plasmid DNA.
simple terms, it was created using a portion of DNA from a virus that had been weakened or killed.
The human immune systems learn to respond to the virus when this DNA fragment is delivered into the body. E Coli cells are used to make the plasmid.
Why is ZyCov – D known as a needle-less vaccine:
Because ZyCov – D is administered by a jet injector.
An injecting syringe is referred to as a jet injector.
A tiny stream of high-pressure liquid penetrates the skin's outermost layer here.
This allows the drug to reach the epidermis' underlying tissues.
This is preferable to the traditional needle approach.
This is due to the fact that the vaccines are transported through the cell plasma membrane and nuclear membrane in this technique.
Conventional approaches, on the other hand, produce low immunogenicity.
Source
à
The Hindu
à
03/12/21
à
Page Number 10
Tags
: DNA, Covid
Subscribe Daily newsletter
Submit
© All Rights reserved. Developed By
Technical Yatra